[Moxonidine is advantageous for hypertensive type 2 diabetic patients. Therapy of hypertension also lowers HbA1c].
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use*; D008790:Metoprolol / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D006442:Glycated Hemoglobin; D007093:Imidazoles; D008790:Metoprolol; D013565:Sympatholytics; C043482:moxonidine